050sek
-2,0 %
Date:2024-07-24Time:17:29:00Latest report:Q1-2024List:First NorthTicker:SCIB
Market Cap:110 msekEnterprise Value:89 msekNet Sales:24,2 msekEarnings:-55,5 msekEmployees:0ISIN:SE0007045414

Ratios

10-year key figure history for Scibase turnover, profit, dividend, equity, PE and PB.

Pre
Pre

Stockprice

Price movement for Scibase with index and moving average MA50 and MA200.

Stockprice:0,50
MA50:0,39
MA200:0,59
Price/MA200:-15,5 %
RSI (14):62,2
Price/MA50:28,7 %

Description

SciBase Holding AB is a medical technology company that develops devices for the evaluation of skin disorders such as skin cancer and atopic dermatitis. SciBase’s products include Nevisense and Nevisense Go and to date, the platform addresses the areas of melanoma detection, non-melanoma skin cancer detection, and skin barrier assessment. It is the only FDA-approved device for the detection of melanoma and the only MDR-approved technology for skin cancer detection in Europe. The company operates in two segments which includes skin cancer and skin barrier assessment. Majority of the revenue is generated from skin cancer segment. Its geographical segments are Europe/Rest of the World, the United States/North America, and Asia/Oceania.

Medical Equipment